Correspondence 0001140361-24-029282 from Elicio Therapeutics, Inc. (ELTX) (CIK 0001601485) (ELTX)
Elicio Therapeutics, Inc. (ELTX) (CIK 0001601485)
Date: June 7, 2024 · CIK: 0001601485 · Accession: 0001140361-24-029282
AI Filing Summary & Sentiment
File numbers found in text: 333-279925
Letter
ELICIO THERAPEUTICS, INC.
451 D Street, 5th Floor
Boston, MA 02210
June 7, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Dickerson, Office of Life Sciences
Re:
Elicio Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 3, 2024
File No. 333-279925 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Elicio Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date and time of the above-referenced Registration Statement to Tuesday, June 11, 2024, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Daniel Bagliebter of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any questions regarding this request.
Very truly yours,
ELICIO THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
ELICIO THERAPEUTICS, INC.
451 D Street, 5th Floor
Boston, MA 02210
June 7, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Dickerson, Office of Life Sciences
Re:
Elicio Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 3, 2024
File No. 333-279925 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Elicio Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the
effective date and time of the above-referenced Registration Statement to Tuesday, June 11, 2024, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Daniel Bagliebter of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any questions regarding this request.
Very truly yours,
ELICIO THERAPEUTICS, INC.
/s/ Robert Connelly
Robert Connelly
Chief Executive Officer
cc:
Elicio Therapeutics, Inc.
Megan Filoon
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
William C. Hicks
Daniel Bagliebter